Stroke and blood clot risk in transgender women taking hormones
BACKGROUND: Many transgender people undergo gender-affirming hormone therapy (HT) to align their physical appearance with their identity. A central part of gender-affirming HT in transfeminine (TF) people is estrogen, which is often taken in combination with testosterone-lowering medications. OBJECT...
| Otros Autores: | , |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Washington, DC :
Patient-Centered Outcomes Research Institute (PCORI)
2021.
|
| Colección: | Final research report
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820264306719 |
